2019 Webinar Series: Therapeutic Area Strategies for DART & Juvenile Toxicity Testing


How does the DART and juvenile toxicology assessment of a gene therapy differ from that of an oncology drug? Are you including the right studies and endpoints?

Therapeutic area can – and should – influence program design. Know for sure with answers from the experts in our new webinar series. Over the course of three presentations, you’ll learn how to design your DART program with the right approach for your therapeutic area and disease state. Discover which studies best assess the potential effects of your agent on male and female reproduction, the developing embryo/fetus, and offspring for an optimum hazard assessment.

Have a scheduling conflict?
Reserve your seat below to receive the on-demand presentations.
3D rendering of an in-vitro fertilization of an egg cell
doctor holding syring and vial

Study Design Considerations for Orphan and Rare Disease Therapies

Thursday, October 10, 2019

View On Demand

vaccine vials lined up in a row

Optimizing Study Designs to Address the Challenges of the Disease State: Diabetes & Gene Therapy

Thursday, October 17, 2019

View On Demand

3D rendering of cancer cells

Speed vs. Safety: Designing Studies for Oncology and Vaccine Products

Thursday, October 24, 2019

View On Demand

Our Next Training & Events